A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity
ACS Chemical Biology · 2026
DOI: 10.1021/acschembio.6c00123 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2026. Verfasst von Yishu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, 132 East Outer Ring Road, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Erb-b2 Receptor Tyrosine Kinases, Vascular Endothelial Growth Factor A, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Sun Yat-sen University, 132 East Outer Ring Road, Guangzhou 510006, China.
ORCID-Profile: Xiaoqing Cai
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Ma, J., Zheng, Z., Fang, T., Sun, H., Li, N., & Cai, X. (2026). A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00123
Vancouver
Zhang Y, Ma J, Zheng Z, Fang T, Sun H, Li N, et al. A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00123
BibTeX
@article{Zhang2026,
author = {Zhang, Yishu and Ma, Jing and Zheng, Zhenting and Fang, Tong and Sun, Huanhuan and Li, Na and Cai, Xiaoqing},
title = {A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity},
journal = {ACS Chemical Biology},
year = {2026},
doi = {10.1021/acschembio.6c00123}
}
EUVIMED